Sharda Cropchem Limited — PPTs, 24-01-2025: Investor Presentation

**Financial Highlights:** For Q3 FY25, Sharda Cropchem reported total revenues of Rs. 929 Cr., marking a 47% increase year-on-year, primarily driven by higher volumes, especially in Europe and NAFTA. The agrochemical segment grew by 51% to Rs. 769 Cr., fueled by a 49.5% increase in volumes. Gross margins improved significantly by 660 basis points to 32.7%. EBITDA rose dramatically to Rs. 157 Cr. from Rs. 47 Cr., leading to a substantial PAT increase to Rs. 31 Cr. from Rs. 5 Cr. in Q3 FY24.

**Strategic Initiatives and Growth Drivers:** The company is focused on forward integration by building its sales force and adopting a factory-to-farmer approach. It plans to expand distribution in existing and new markets, continually invest in product registrations, and enhance operational efficiencies.

**Business Developments:** Sharda has a robust pipeline with 2,948 registrations and 1,047 applications pending. The company's asset-light model helps maintain competitiveness and allows flexibility in operations.

**Market Position and Competitive Advantage:** Operating in over 80 countries, Sharda's wide distribution network and competitive sourcing arrangements bolster its position in the global agrochemical marketplace.

**Investor Implications:** With solid revenue growth, improving margins, and strategic expansion plans, investors should view Sharda Cropchem favorably for ongoing and future growth potential.